Radiation therapy remains a cornerstone in the management of breast cancer, improving local control and survival for a large proportion of patients. More than eighty percent of individuals with breast cancer receive postoperative radiation, making it an essential component of modern treatment strategies. At the same time, the proximity of the heart to the radiation field in left-sided disease continues to raise concerns about cardiac toxicity.
Historically, radiation-induced heart disease has been considered a late complication that emerges years after treatment. However, growing evidence suggests that cardiac injury may begin much earlier, often in a silent and subclinical form that escapes routine detection. A recent prospective study explored this question by examining whether early cardiac injury can be identified shortly after radiation therapy using advanced imaging techniques.
This study, recently published in the International Journal of Radiation Oncology, Biology, Physics (Red Journal), explores an important and often overlooked question in breast cancer care: can radiation therapy cause early, subclinical cardiac injury that remains undetected by conventional methods?
Title: “Radiation-Induced Acute Cardiac Injury in Patients With Left-Sided Breast Cancer: A Cardiac Magnetic Resonance Study on the Dose-Response Relation”
Authors:Linlin Zheng, Mengxi Yang, Cheng Luo, Xinyu Lv, Ke Yuan, Ke Xu, Wenting Xu, Yuntao Hu,Quan Dai, Jia Xu, Junjie Li, Jinyi Lang, Peng Zhou and Jun Yin
Capturing Early Changes Through Advanced Imaging
In this prospective cohort, sixty-four women with left-sided breast cancer underwent cardiac evaluation before and after radiation therapy. Patients were treated with either whole-breast radiation therapy or chest wall radiation combined with regional nodal irradiation, reflecting common clinical approaches.
The study used cardiac magnetic resonance imaging to assess cardiac structure and function. This technique is widely regarded as the most accurate method for evaluating myocardial performance. Importantly, it allows for the measurement of myocardial strain, a sensitive indicator of subtle changes in cardiac function that may precede detectable alterations in conventional parameters such as left ventricular ejection fraction.
The Impact of Radiation Dose on the Heart
A clear distinction emerged between treatment groups in terms of cardiac exposure. Patients receiving chest wall and nodal irradiation were exposed to significantly higher radiation doses to both the whole heart and the left ventricle compared with those receiving whole-breast radiation alone.
The mean heart dose approached nine gray in the more extensive radiation group, whereas it remained below three gray in the whole-breast group. These differences were mirrored in left ventricular exposure.
Beyond the overall dose, the distribution of radiation within the heart was uneven. The apical region of the left ventricle received the highest exposure, highlighting the importance of understanding regional dose patterns rather than relying solely on global metrics.
When Conventional Tests Remain Silent
Despite measurable radiation exposure, standard methods of cardiac assessment did not reveal significant abnormalities. Left ventricular ejection fraction remained stable, and biomarkers such as troponin and natriuretic peptides showed no meaningful changes. Echocardiographic findings were similarly unremarkable.
This apparent absence of injury could easily be interpreted as reassurance. However, more sensitive imaging told a different story.
Strain Imaging Uncovers Subclinical Dysfunction
Cardiac magnetic resonance strain analysis revealed early signs of myocardial dysfunction that were not detectable by conventional methods. In patients receiving higher radiation doses, global longitudinal strain and global circumferential strain declined significantly after treatment.
These changes were observed within days of completing radiation therapy, indicating that cardiac injury begins almost immediately. Regional analysis showed that the most pronounced reductions occurred in the apical and middle segments of the left ventricle, which corresponded to areas receiving higher radiation exposure.
This relationship between dose distribution and functional impairment supports the concept of a direct dose response effect on myocardial tissue.
Early Dysfunction and Clinical Implications
Although patients remained asymptomatic, the clinical relevance of these findings is substantial. Approximately fifteen percent of participants developed cancer therapy related cardiac dysfunction shortly after radiation therapy.
The majority of these cases occurred in patients exposed to higher cardiac doses. Furthermore, the combination of radiation dose and baseline cardiovascular risk, assessed using the SCORE2 index, improved the prediction of which patients would develop dysfunction.
These findings emphasize that cardiotoxicity is influenced not only by treatment intensity but also by the individual patient profile.
Can Radiotherapy “Wake Up” The Immune System In Pancreatic Cancer 2026 ?
Understanding the Mechanisms of Early Injury
Radiation induced cardiac injury begins at the cellular level. Endothelial cells are particularly sensitive to radiation, and even relatively low doses can disrupt vascular integrity. This leads to increased permeability, inflammatory activation, and microvascular thrombosis.
These early events can produce myocardial edema, which was detected in a subset of patients on imaging. Over time, persistent injury may lead to fibrosis and permanent structural damage.
The observed reduction in myocardial strain likely reflects this early phase of injury, occurring before overt functional decline becomes apparent.
Why Strain Matters More Than Ejection Fraction
Left ventricular ejection fraction has long been the standard parameter for assessing cardiac function. However, it lacks sensitivity for detecting early or subtle myocardial injury. By the time ejection fraction declines, damage is often advanced and less reversible.
In contrast, myocardial strain provides a more sensitive measure of cardiac performance. It reflects the deformation of myocardial fibers during contraction and can identify dysfunction at an earlier stage.
Implications for Radiation Oncology Practice
These results reinforce the importance of minimizing cardiac exposure during radiation therapy, particularly in left-sided breast cancer. Modern techniques such as deep inspiration breath hold and advanced planning strategies have already contributed to reducing heart dose, but further optimization remains essential.
At the same time, risk assessment should incorporate both treatment related factors and patient specific cardiovascular risk. Identifying high risk individuals allows for more targeted monitoring and early intervention.
A New Perspective on Cardiotoxicity
Radiation induced cardiac injury should no longer be viewed solely as a late complication. Instead, it represents a continuum that begins during or shortly after treatment, often in a subclinical form.
The ability to detect early changes using advanced imaging offers an opportunity to intervene before irreversible damage occurs. Cardiac magnetic resonance strain analysis provides a powerful tool to achieve this goal.
This study highlights a critical shift in understanding. What appears clinically silent may already be biologically active, and early detection may ultimately determine long term outcomes for patients with breast cancer.
Discover more articles like this on OncoDaily.
Written by Nare Hovhannisyan, MD